Startups

Xyall is a global innovator in molecular pathology.

Summary

Seedtable Score
  • 17
Locations
Company Size
  • 1 to 10 employees
Last Stage Round
  • Series B

Total funding Amount

$12M

Fundraising History

  • Series B
    $6.3M
  • Jan 01 '20 Series B
    $5.6M

Investors